YALE-SCORE ON SEX DIFFERENCES IN ALCOHOL USE DISORDER
YALE-SCORE ON SEX DIFFERENCES IN ALCOHOL USE DISORDER
批准号:
10357878
负责人:
SHERRY ANN MCKEE
金额:
$167.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-03-10 至 2025-02-28
关键词:
AccountingAddressAffectAlcohol consumptionAlcoholsAreaAwardBasic ScienceBehavioralBiologicalBiologyBiomedical ResearchBrainCardiovascular DiseasesCenters of Research ExcellenceClinical SciencesCognitive deficitsCollaborationsCommunitiesConsultationsDataDevelopmentEnsureEnvironmentEthanol MetabolismFDA approvedFacultyFundingGoalsGonadal Steroid HormonesHealthHealthcareInfrastructureInstitutesInstitutionLaboratoriesLeadershipMalignant NeoplasmsMentorsModelingMorbidity - disease rateNational Institute on Alcohol Abuse and AlcoholismNegative ReinforcementsNeurobiologyNeuroimmuneNeurosciencesPharmaceutical PreparationsPoliciesPositive ReinforcementsPositron-Emission TomographyPsychiatryPublic HealthPublicationsResearchResearch PersonnelResearch PriorityResourcesRewardsRiskRoleSamplingSex DifferencesSideSpecialized CenterStressStructureSubstance abuse problemSystemTeacher Professional DevelopmentTherapeuticTimeTranslatingTranslational ResearchTranslationsUnited StatesWithdrawalWomanWomen&aposs Healthaddictionalcohol abuse therapyalcohol use disorderbehavioral pharmacologycerebral atrophycostdrinkingexperiencefaculty supporthealthspanheuristicshypothalamic-pituitary-adrenal axisimprovedinterestliver inflammationmenmetabolomicsmortalitynegative affectneuroadaptationneurochemistryneurotoxicitynext generationnovel therapeuticsoutreachoutreach programprogramsrecruitresponsesexsuccesstherapeutic targettranslational approachtranslational pipelinetranslational scientist
中文摘要
我们提议的耶鲁大学卓越研究中心(SCORE)关于酒精使用的性别差异
疾病(AUD)汇集了一个领先的基础和临床科学专家团队,
跨学科,翻译,跨物种的研究计划,旨在确定新的治疗方法,
解决最近女性澳元汇率飙升的问题。在过去的10年里,妇女的澳元比率
增加了84%,在美国有1050万女性。酒精使用是第三大
在美国,可预防的发病率和死亡率的原因,
与男性相比,饮酒对健康的危害更大。FDA批准的AUD药物
相对较低的功效,所有这些都是用男性样本开发的,没有一个目标因素,
保持女性饮酒。大量数据表明,女性更有可能喝酒,
调节负面情绪和压力,而男性更容易因酒精相关的积极因素而饮酒
加固. Koob和Volkow 194已经开发了成瘾循环的启发式框架,其中
“戒断/负面情绪阶段”包括因压力和其他负面情绪状态而饮酒,
被称为“上瘾的黑暗面”。在这个阶段的神经适应识别奖励赤字和压力
饮酒过量,导致强迫性饮酒。我们使用这个负强化模型来指导我们的研究,
计划针对关键的大脑结构,神经化学系统,HPA轴活动,神经免疫功能,酒精
代谢,和性类固醇激素,这是假设差异激励酒精消费
在女人身上。到目前为止,还没有一个协调一致的努力,将性别作为一个生物变量(SABV)
开发AUD药物。因此,我们的耶鲁评分的重点代表了高研究
NIAAA和ORWH的优先主题。我们提出了三个项目,将有相互关联和共享
目标,每个目标都提供了独特的贡献,以告知和加快AUD治疗的发展
对于AUD的女性来说。这些项目将得到三个核心和一个体制环境的支持,
卓越的资源和基础设施,以支持转化科学。我们的具体目标和目的
耶鲁评分是:目标1:使用神经生物学的方法,专注于“黑暗的一面,
成瘾“,以告知和加速针对压力的适合性别的治疗方法的发展,
负面影响,这差异保持妇女饮酒。目的2:导师评分-早期研究者
成为下一代专注于酒精和女性健康的生物医学和行为研究人员
跨越T1到T4平移谱。目标3:成为机构、区域和国家资源
通过提供T1到T4翻译,激发对与酒精使用相关的性别差异的研究
专家咨询,支持教师培训奖,利用国家性和酒精使用数据,
为治疗和政策提供信息,并提供一个推广和传播方案。
英文摘要
Our proposed Yale-Specialized Center of Research Excellence (SCORE) on sex differences in alcohol use
disorder (AUD) brings together a team of leading basic and clinical science experts to pursue an
interdisciplinary, translational, cross-species program of research aimed at identifying novel therapeutics to
address the recent surge in rates of AUD in women. Over the past 10 years, rates of AUD in women have
increased by 84%, translating to 10.5 million women across the United States. Alcohol use is the third leading
cause of preventable morbidity and mortality in the United States and women drinkers experience exacerbated
health risks associated with alcohol consumption when compared to men. FDA-approved medications for AUD
have relatively low efficacy, all were developed with samples of men, and none target factors that differentially
maintain drinking in women. A considerable body of data identifies that women are more likely to drink to
regulate negative affect and stress, while men are more likely to drink for alcohol-related positive
reinforcement. Koob & Volkow194 have developed a heuristic framework of the addiction cycle, where the
‘withdrawal/negative affect stage’ involves drinking motivated by stress and other negative affect states, also
termed ‘the dark side of addiction’. Neuroadaptations during this stage identify reward deficits and stress
surfeits, which drive compulsive drinking. Using this negative reinforcement model to guide our research, we
plan to target key brain structures, neurochemical systems, HPA-axis activity, neuroimmune function, alcohol
metabolism, and sex steroid hormones, which are hypothesized to differentially motivate alcohol consumption
in women. To date, there has not been a concerted effort to incorporate sex as a biological variable (SABV)
into AUD medication development. Consequently, the focus of our Yale-SCORE represents a high research
priority topic for both NIAAA and ORWH. We propose three Projects that will have inter-related and shared
goals, with each providing unique contributions to inform and expedite the development of AUD therapeutics
for women with AUD. The Projects will be supported by three Cores and an institutional environment with
exceptional resources and infrastructure to support translational science. Our specific aims and objectives of
the Yale-SCORE are to: AIM 1: Use a neurobiologically-informed approach focusing on the ‘dark side of
addiction’ to inform and expedite the development of sex-appropriate therapeutics targeting stress and
negative affect, which differentially maintain drinking in women. AIM 2: Mentor SCORE-Early Investigators to
become the next generation of biomedical and behavioral researchers focused on alcohol and women’s health
spanning the T1 to T4 translational spectrum. AIM 3: Be an institutional, regional, and national resource
galvanizing the study of sex differences in relation to alcohol use across T1 to T4 translation by providing
expert consultation, supporting faculty training awards, leveraging national data on sex and alcohol use to
inform treatment and policy, and providing a program of outreach and dissemination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 2 study examining efficacy and mechanisms of combining varenicline and guanfacine for smoking cessation in women and men
-
批准号:10398931
-
项目类别:
-
资助金额:$79.5万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Leadership Administrative Core
-
批准号:10357879
-
项目类别:
-
资助金额:$67.38万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
PROJECT 1: Targeting stress-reactivity and noradrenergic mechanisms for sex-appropriate alcohol use disorder treatment.
-
批准号:10357882
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Leadership Administrative Core
-
批准号:10599819
-
项目类别:
-
资助金额:$46.78万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
PROJECT 1: Targeting stress-reactivity and noradrenergic mechanisms for sex-appropriate alcohol use disorder treatment.
-
批准号:10599822
-
项目类别:
-
资助金额:$27.17万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Yale-SCORE NIMH Data Archive
-
批准号:10347940
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase 2 study examining efficacy and mechanisms of combining varenicline and guanfacine for smoking cessation in women and men
-
批准号:10192689
-
项目类别:
-
资助金额:$79.5万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase 2 study examining efficacy and mechanisms of combining varenicline and guanfacine for smoking cessation in women and men
-
批准号:9886547
-
项目类别:
-
资助金额:$75.5万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
YALE-SCORE ON SEX DIFFERENCES IN ALCOHOL USE DISORDER
-
批准号:10599817
-
项目类别:
-
资助金额:$167.5万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Does Guanfacine, an alpha2 adrenergic agonist, attenuate stress-induced drinking?
-
批准号:8631313
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2014
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Does Guanfacine, an alpha2 adrenergic agonist, attenuate stress-induced drinking?
-
批准号:9212067
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2014
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Does Guanfacine, an alpha2 adrenergic agonist, attenuate stress-induced drinking?
-
批准号:8794388
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2014
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
-
批准号:8841703
-
项目类别:
-
资助金额:$80.69万
-
财政年份:2013
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation: Administrative Supplement
-
批准号:8815787
-
项目类别:
-
资助金额:$10.9万
-
财政年份:2013
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
-
批准号:8675821
-
项目类别:
-
资助金额:$71.2万
-
财政年份:2013
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
-
批准号:8577631
-
项目类别:
-
资助金额:$65.58万
-
财政年份:2013
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Yale SCOR on Gender-Sensitive Treatment for Tobacco Dependence
-
批准号:8345893
-
项目类别:
-
资助金额:$122.98万
-
财政年份:2012
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Sex-Appropriate Treatment Development for Alcohol Use Disorders
-
批准号:9794638
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2012
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Yale SCOR on Gender-Sensitive Treatment for Tobacco Dependence
-
批准号:8870320
-
项目类别:
-
资助金额:$117.02万
-
财政年份:2012
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Does doxazosin attenuate stress-induced smoking and improve clinical outcomes?
-
批准号:8292606
-
项目类别:
-
资助金额:$24.91万
-
财政年份:2012
-
负责人:SHERRY ANN MCKEE
-
依托单位:
海外基金